Feasibility Study of Non-Expanded Autologous Adipose Tissue Derived Stromal Vascular Fraction Cells in Disease Modifying Anti-Rheumatic Drugs (DMARD) Resistant Rheumatoid Arthritis
Status: Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Stromal vascular fraction (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Translational Biosciences
- 31 Aug 2018 Biomarkers information updated
- 16 Sep 2015 Status changed from active, no longer recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 21 Jan 2015 Status changed from recruiting to active, no longer recruiting according to the ClinicalTrials.gov record.